Axcella Health Inc. (AXLA) Financial Statements (2025 and earlier)

Company Profile

Business Address 840 MEMORIAL DRIVE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:17,14755,000107,300 
Cash and cash equivalents17,14723,57471,590 
Short-term investments  1,59835,739 
Other undisclosed cash, cash equivalents, and short-term investments  29,828(29) 
Other undisclosed current assets8761,6461,72193,540
Total current assets:18,02356,646109,02193,540
Noncurrent Assets
Property, plant and equipment693870360608
Other noncurrent assets 211211  
Other undisclosed noncurrent assets   211211
Total noncurrent assets:9041,081571819
TOTAL ASSETS:18,92757,727109,59294,359
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,55610,1507,7848,356
Accounts payable4,7074,3012,2901,998
Accrued liabilities7,8495,8495,4946,358
Other undisclosed current liabilities1,592   
Total current liabilities:14,14810,1507,7848,356
Noncurrent Liabilities
Long-term debt and lease obligation  25,070  
Long-term debt, excluding current maturities  25,070  
Liabilities, other than long-term debt 6154991,205882
Other liabilities 464991,205882
Operating lease, liability 569   
Other undisclosed noncurrent liabilities   25,22224,897
Total noncurrent liabilities: 61525,56926,42725,779
Total liabilities:14,76335,71934,21134,135
Equity
Equity, attributable to parent4,16422,00875,38160,224
Common stock74403824
Additional paid in capital422,517359,261347,990276,286
Accumulated other comprehensive loss  (52)(34) 
Accumulated deficit(418,427)(337,241)(272,613)(216,086)
Total equity:4,16422,00875,38160,224
TOTAL LIABILITIES AND EQUITY:18,92757,727109,59294,359

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues    1,814
Net investment income    1,814
Gross profit:    1,814
Operating expenses(76,988)(61,846)(53,836)(57,439)
Other undisclosed operating income (loss) 100  (1,814)
Operating loss:(76,988)(61,846)(53,836)(57,439)
Nonoperating expense(4,198)(2,782)(2,691)(1,598)
Other nonoperating income (expense)(80)(4)10(1,598)
Interest and debt expense(1,601)(2,917)(3,007)(3,395)
Loss from continuing operations:(82,787)(67,545)(59,534)(62,432)
Loss before gain (loss) on sale of properties:(67,545)(59,534)(62,432)
Net loss:(82,787)(67,545)(59,534)(62,432)
Other undisclosed net income attributable to parent1,6012,9173,0073,395
Net loss attributable to parent:(81,186)(64,628)(56,527)(59,037)
Preferred stock dividends and other adjustments    (46)
Net loss available to common stockholders, diluted:(81,186)(64,628)(56,527)(59,083)

Comprehensive Income ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(82,787)(67,545)(59,534)(62,432)
Comprehensive loss:(82,787)(67,545)(59,534)(62,432)
Other undisclosed comprehensive income, net of tax, attributable to parent1,6532,8992,973 
Comprehensive loss, net of tax, attributable to parent:(81,134)(64,646)(56,561)(62,432)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: